Substituted biaryl oxazoles, imidazoles, and thiazoles as sodium channel blockers

A series of low molecular weight biaryl substituted oxazoles, imidazoles, and thiazoles were identified as Na v1.7 blockers. These state dependent sodium channel blockers were synthesized and evaluated for treatment of neuropathic pain. Voltage-gated sodium channels have been shown to play a critica...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry letters 2010-09, Vol.20 (18), p.5536-5540
Hauptverfasser: Tyagarajan, Sriram, Chakravarty, Prasun K., Zhou, Bishan, Fisher, Michael H., Wyvratt, Mathew J., Lyons, Kathy, Klatt, Tracy, Li, Xiaohua, Kumar, Sanjeev, Williams, Brande, Felix, John, Priest, Birgit T., Brochu, Richard M., Warren, Vivien, Smith, McHardy, Garcia, Maria, Kaczorowski, Gregory J., Martin, William J., Abbadie, Catherine, McGowan, Erin, Jochnowitz, Nina, Parsons, William H.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 5540
container_issue 18
container_start_page 5536
container_title Bioorganic & medicinal chemistry letters
container_volume 20
creator Tyagarajan, Sriram
Chakravarty, Prasun K.
Zhou, Bishan
Fisher, Michael H.
Wyvratt, Mathew J.
Lyons, Kathy
Klatt, Tracy
Li, Xiaohua
Kumar, Sanjeev
Williams, Brande
Felix, John
Priest, Birgit T.
Brochu, Richard M.
Warren, Vivien
Smith, McHardy
Garcia, Maria
Kaczorowski, Gregory J.
Martin, William J.
Abbadie, Catherine
McGowan, Erin
Jochnowitz, Nina
Parsons, William H.
description A series of low molecular weight biaryl substituted oxazoles, imidazoles, and thiazoles were identified as Na v1.7 blockers. These state dependent sodium channel blockers were synthesized and evaluated for treatment of neuropathic pain. Voltage-gated sodium channels have been shown to play a critical role in neuropathic pain. With a goal to develop potent peripherally active sodium channel blockers, a series of low molecular weight biaryl substituted imidazoles, oxazoles, and thiazole carboxamides were identified with good in vitro and in vivo potency.
doi_str_mv 10.1016/j.bmcl.2010.07.064
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_954592005</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0960894X10010206</els_id><sourcerecordid>954592005</sourcerecordid><originalsourceid>FETCH-LOGICAL-c417t-a704446ec8a3aa18fed1ceabf5bf633c7e32ffef8c00427ef26f4ecc4f8cd8d63</originalsourceid><addsrcrecordid>eNqFkEtv1DAQgC1ERZfCH-CAckFcyDJ-JE4kLlXFS6qEECBxs5zxWPXiJMVOUMuvx6vdwq2c5qFvHvoYe8Zhy4G3r3fbYcS4FVAaoLfQqgdsw1Wraqmgecg20LdQd736fsoe57wD4AqUesROBWjom0Zs2Ocv65CXsKwLuWoINt3Gar6xv-dI-VUVxuDucju5arkKh7KyucqzC-tY4ZWdJorVEGf8QSk_YSfexkxPj_GMfXv39uvFh_ry0_uPF-eXNSqul9rq8opqCTsrreWdJ8eR7OCbwbdSoiYpvCffIYASmrxovSJEVTquc608Yy8Pe6_T_HOlvJgxZKQY7UTzmk3fqKYXAM1_Sd2oorDXspDiQGKac07kzXUKY5FiOJi9c7Mze-dm79yANsV5GXp-XL8OI7m_I3eSC_DiCNiMNvpkJwz5HyeF6iTsr785cFS0_QqUTMZAE5ILiXAxbg73_fEHo3ehOg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>754010973</pqid></control><display><type>article</type><title>Substituted biaryl oxazoles, imidazoles, and thiazoles as sodium channel blockers</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Tyagarajan, Sriram ; Chakravarty, Prasun K. ; Zhou, Bishan ; Fisher, Michael H. ; Wyvratt, Mathew J. ; Lyons, Kathy ; Klatt, Tracy ; Li, Xiaohua ; Kumar, Sanjeev ; Williams, Brande ; Felix, John ; Priest, Birgit T. ; Brochu, Richard M. ; Warren, Vivien ; Smith, McHardy ; Garcia, Maria ; Kaczorowski, Gregory J. ; Martin, William J. ; Abbadie, Catherine ; McGowan, Erin ; Jochnowitz, Nina ; Parsons, William H.</creator><creatorcontrib>Tyagarajan, Sriram ; Chakravarty, Prasun K. ; Zhou, Bishan ; Fisher, Michael H. ; Wyvratt, Mathew J. ; Lyons, Kathy ; Klatt, Tracy ; Li, Xiaohua ; Kumar, Sanjeev ; Williams, Brande ; Felix, John ; Priest, Birgit T. ; Brochu, Richard M. ; Warren, Vivien ; Smith, McHardy ; Garcia, Maria ; Kaczorowski, Gregory J. ; Martin, William J. ; Abbadie, Catherine ; McGowan, Erin ; Jochnowitz, Nina ; Parsons, William H.</creatorcontrib><description>A series of low molecular weight biaryl substituted oxazoles, imidazoles, and thiazoles were identified as Na v1.7 blockers. These state dependent sodium channel blockers were synthesized and evaluated for treatment of neuropathic pain. Voltage-gated sodium channels have been shown to play a critical role in neuropathic pain. With a goal to develop potent peripherally active sodium channel blockers, a series of low molecular weight biaryl substituted imidazoles, oxazoles, and thiazole carboxamides were identified with good in vitro and in vivo potency.</description><identifier>ISSN: 0960-894X</identifier><identifier>EISSN: 1464-3405</identifier><identifier>DOI: 10.1016/j.bmcl.2010.07.064</identifier><identifier>PMID: 20709552</identifier><language>eng</language><publisher>Amsterdam: Elsevier Ltd</publisher><subject>Analgesics ; Animals ; Biaryl imidazoles ; Biaryl oxazoles ; Biaryl thiazoles ; Biological and medical sciences ; Dogs ; Humans ; Imidazoles - chemistry ; Imidazoles - metabolism ; Imidazoles - pharmacology ; Imidazoles - therapeutic use ; Medical sciences ; Microsomes, Liver - metabolism ; Na v1.7 blockers ; NAV1.7 Voltage-Gated Sodium Channel ; Neuralgia - drug therapy ; Neuropathic pain ; Neuropathy ; Neuropharmacology ; Oxazoles - chemistry ; Oxazoles - metabolism ; Oxazoles - pharmacology ; Oxazoles - therapeutic use ; Pharmacology. Drug treatments ; Rats ; Sodium Channel Blockers - chemistry ; Sodium Channel Blockers - metabolism ; Sodium Channel Blockers - pharmacology ; Sodium Channel Blockers - therapeutic use ; Sodium Channels - metabolism ; Thiazoles - chemistry ; Thiazoles - metabolism ; Thiazoles - pharmacology ; Thiazoles - therapeutic use ; Voltage-gated sodium channel</subject><ispartof>Bioorganic &amp; medicinal chemistry letters, 2010-09, Vol.20 (18), p.5536-5540</ispartof><rights>2010 Elsevier Ltd</rights><rights>2015 INIST-CNRS</rights><rights>Copyright (c) 2010 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c417t-a704446ec8a3aa18fed1ceabf5bf633c7e32ffef8c00427ef26f4ecc4f8cd8d63</citedby><cites>FETCH-LOGICAL-c417t-a704446ec8a3aa18fed1ceabf5bf633c7e32ffef8c00427ef26f4ecc4f8cd8d63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0960894X10010206$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=23248303$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20709552$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tyagarajan, Sriram</creatorcontrib><creatorcontrib>Chakravarty, Prasun K.</creatorcontrib><creatorcontrib>Zhou, Bishan</creatorcontrib><creatorcontrib>Fisher, Michael H.</creatorcontrib><creatorcontrib>Wyvratt, Mathew J.</creatorcontrib><creatorcontrib>Lyons, Kathy</creatorcontrib><creatorcontrib>Klatt, Tracy</creatorcontrib><creatorcontrib>Li, Xiaohua</creatorcontrib><creatorcontrib>Kumar, Sanjeev</creatorcontrib><creatorcontrib>Williams, Brande</creatorcontrib><creatorcontrib>Felix, John</creatorcontrib><creatorcontrib>Priest, Birgit T.</creatorcontrib><creatorcontrib>Brochu, Richard M.</creatorcontrib><creatorcontrib>Warren, Vivien</creatorcontrib><creatorcontrib>Smith, McHardy</creatorcontrib><creatorcontrib>Garcia, Maria</creatorcontrib><creatorcontrib>Kaczorowski, Gregory J.</creatorcontrib><creatorcontrib>Martin, William J.</creatorcontrib><creatorcontrib>Abbadie, Catherine</creatorcontrib><creatorcontrib>McGowan, Erin</creatorcontrib><creatorcontrib>Jochnowitz, Nina</creatorcontrib><creatorcontrib>Parsons, William H.</creatorcontrib><title>Substituted biaryl oxazoles, imidazoles, and thiazoles as sodium channel blockers</title><title>Bioorganic &amp; medicinal chemistry letters</title><addtitle>Bioorg Med Chem Lett</addtitle><description>A series of low molecular weight biaryl substituted oxazoles, imidazoles, and thiazoles were identified as Na v1.7 blockers. These state dependent sodium channel blockers were synthesized and evaluated for treatment of neuropathic pain. Voltage-gated sodium channels have been shown to play a critical role in neuropathic pain. With a goal to develop potent peripherally active sodium channel blockers, a series of low molecular weight biaryl substituted imidazoles, oxazoles, and thiazole carboxamides were identified with good in vitro and in vivo potency.</description><subject>Analgesics</subject><subject>Animals</subject><subject>Biaryl imidazoles</subject><subject>Biaryl oxazoles</subject><subject>Biaryl thiazoles</subject><subject>Biological and medical sciences</subject><subject>Dogs</subject><subject>Humans</subject><subject>Imidazoles - chemistry</subject><subject>Imidazoles - metabolism</subject><subject>Imidazoles - pharmacology</subject><subject>Imidazoles - therapeutic use</subject><subject>Medical sciences</subject><subject>Microsomes, Liver - metabolism</subject><subject>Na v1.7 blockers</subject><subject>NAV1.7 Voltage-Gated Sodium Channel</subject><subject>Neuralgia - drug therapy</subject><subject>Neuropathic pain</subject><subject>Neuropathy</subject><subject>Neuropharmacology</subject><subject>Oxazoles - chemistry</subject><subject>Oxazoles - metabolism</subject><subject>Oxazoles - pharmacology</subject><subject>Oxazoles - therapeutic use</subject><subject>Pharmacology. Drug treatments</subject><subject>Rats</subject><subject>Sodium Channel Blockers - chemistry</subject><subject>Sodium Channel Blockers - metabolism</subject><subject>Sodium Channel Blockers - pharmacology</subject><subject>Sodium Channel Blockers - therapeutic use</subject><subject>Sodium Channels - metabolism</subject><subject>Thiazoles - chemistry</subject><subject>Thiazoles - metabolism</subject><subject>Thiazoles - pharmacology</subject><subject>Thiazoles - therapeutic use</subject><subject>Voltage-gated sodium channel</subject><issn>0960-894X</issn><issn>1464-3405</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkEtv1DAQgC1ERZfCH-CAckFcyDJ-JE4kLlXFS6qEECBxs5zxWPXiJMVOUMuvx6vdwq2c5qFvHvoYe8Zhy4G3r3fbYcS4FVAaoLfQqgdsw1Wraqmgecg20LdQd736fsoe57wD4AqUesROBWjom0Zs2Ocv65CXsKwLuWoINt3Gar6xv-dI-VUVxuDucju5arkKh7KyucqzC-tY4ZWdJorVEGf8QSk_YSfexkxPj_GMfXv39uvFh_ry0_uPF-eXNSqul9rq8opqCTsrreWdJ8eR7OCbwbdSoiYpvCffIYASmrxovSJEVTquc608Yy8Pe6_T_HOlvJgxZKQY7UTzmk3fqKYXAM1_Sd2oorDXspDiQGKac07kzXUKY5FiOJi9c7Mze-dm79yANsV5GXp-XL8OI7m_I3eSC_DiCNiMNvpkJwz5HyeF6iTsr785cFS0_QqUTMZAE5ILiXAxbg73_fEHo3ehOg</recordid><startdate>20100915</startdate><enddate>20100915</enddate><creator>Tyagarajan, Sriram</creator><creator>Chakravarty, Prasun K.</creator><creator>Zhou, Bishan</creator><creator>Fisher, Michael H.</creator><creator>Wyvratt, Mathew J.</creator><creator>Lyons, Kathy</creator><creator>Klatt, Tracy</creator><creator>Li, Xiaohua</creator><creator>Kumar, Sanjeev</creator><creator>Williams, Brande</creator><creator>Felix, John</creator><creator>Priest, Birgit T.</creator><creator>Brochu, Richard M.</creator><creator>Warren, Vivien</creator><creator>Smith, McHardy</creator><creator>Garcia, Maria</creator><creator>Kaczorowski, Gregory J.</creator><creator>Martin, William J.</creator><creator>Abbadie, Catherine</creator><creator>McGowan, Erin</creator><creator>Jochnowitz, Nina</creator><creator>Parsons, William H.</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20100915</creationdate><title>Substituted biaryl oxazoles, imidazoles, and thiazoles as sodium channel blockers</title><author>Tyagarajan, Sriram ; Chakravarty, Prasun K. ; Zhou, Bishan ; Fisher, Michael H. ; Wyvratt, Mathew J. ; Lyons, Kathy ; Klatt, Tracy ; Li, Xiaohua ; Kumar, Sanjeev ; Williams, Brande ; Felix, John ; Priest, Birgit T. ; Brochu, Richard M. ; Warren, Vivien ; Smith, McHardy ; Garcia, Maria ; Kaczorowski, Gregory J. ; Martin, William J. ; Abbadie, Catherine ; McGowan, Erin ; Jochnowitz, Nina ; Parsons, William H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c417t-a704446ec8a3aa18fed1ceabf5bf633c7e32ffef8c00427ef26f4ecc4f8cd8d63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Analgesics</topic><topic>Animals</topic><topic>Biaryl imidazoles</topic><topic>Biaryl oxazoles</topic><topic>Biaryl thiazoles</topic><topic>Biological and medical sciences</topic><topic>Dogs</topic><topic>Humans</topic><topic>Imidazoles - chemistry</topic><topic>Imidazoles - metabolism</topic><topic>Imidazoles - pharmacology</topic><topic>Imidazoles - therapeutic use</topic><topic>Medical sciences</topic><topic>Microsomes, Liver - metabolism</topic><topic>Na v1.7 blockers</topic><topic>NAV1.7 Voltage-Gated Sodium Channel</topic><topic>Neuralgia - drug therapy</topic><topic>Neuropathic pain</topic><topic>Neuropathy</topic><topic>Neuropharmacology</topic><topic>Oxazoles - chemistry</topic><topic>Oxazoles - metabolism</topic><topic>Oxazoles - pharmacology</topic><topic>Oxazoles - therapeutic use</topic><topic>Pharmacology. Drug treatments</topic><topic>Rats</topic><topic>Sodium Channel Blockers - chemistry</topic><topic>Sodium Channel Blockers - metabolism</topic><topic>Sodium Channel Blockers - pharmacology</topic><topic>Sodium Channel Blockers - therapeutic use</topic><topic>Sodium Channels - metabolism</topic><topic>Thiazoles - chemistry</topic><topic>Thiazoles - metabolism</topic><topic>Thiazoles - pharmacology</topic><topic>Thiazoles - therapeutic use</topic><topic>Voltage-gated sodium channel</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tyagarajan, Sriram</creatorcontrib><creatorcontrib>Chakravarty, Prasun K.</creatorcontrib><creatorcontrib>Zhou, Bishan</creatorcontrib><creatorcontrib>Fisher, Michael H.</creatorcontrib><creatorcontrib>Wyvratt, Mathew J.</creatorcontrib><creatorcontrib>Lyons, Kathy</creatorcontrib><creatorcontrib>Klatt, Tracy</creatorcontrib><creatorcontrib>Li, Xiaohua</creatorcontrib><creatorcontrib>Kumar, Sanjeev</creatorcontrib><creatorcontrib>Williams, Brande</creatorcontrib><creatorcontrib>Felix, John</creatorcontrib><creatorcontrib>Priest, Birgit T.</creatorcontrib><creatorcontrib>Brochu, Richard M.</creatorcontrib><creatorcontrib>Warren, Vivien</creatorcontrib><creatorcontrib>Smith, McHardy</creatorcontrib><creatorcontrib>Garcia, Maria</creatorcontrib><creatorcontrib>Kaczorowski, Gregory J.</creatorcontrib><creatorcontrib>Martin, William J.</creatorcontrib><creatorcontrib>Abbadie, Catherine</creatorcontrib><creatorcontrib>McGowan, Erin</creatorcontrib><creatorcontrib>Jochnowitz, Nina</creatorcontrib><creatorcontrib>Parsons, William H.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tyagarajan, Sriram</au><au>Chakravarty, Prasun K.</au><au>Zhou, Bishan</au><au>Fisher, Michael H.</au><au>Wyvratt, Mathew J.</au><au>Lyons, Kathy</au><au>Klatt, Tracy</au><au>Li, Xiaohua</au><au>Kumar, Sanjeev</au><au>Williams, Brande</au><au>Felix, John</au><au>Priest, Birgit T.</au><au>Brochu, Richard M.</au><au>Warren, Vivien</au><au>Smith, McHardy</au><au>Garcia, Maria</au><au>Kaczorowski, Gregory J.</au><au>Martin, William J.</au><au>Abbadie, Catherine</au><au>McGowan, Erin</au><au>Jochnowitz, Nina</au><au>Parsons, William H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Substituted biaryl oxazoles, imidazoles, and thiazoles as sodium channel blockers</atitle><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle><addtitle>Bioorg Med Chem Lett</addtitle><date>2010-09-15</date><risdate>2010</risdate><volume>20</volume><issue>18</issue><spage>5536</spage><epage>5540</epage><pages>5536-5540</pages><issn>0960-894X</issn><eissn>1464-3405</eissn><abstract>A series of low molecular weight biaryl substituted oxazoles, imidazoles, and thiazoles were identified as Na v1.7 blockers. These state dependent sodium channel blockers were synthesized and evaluated for treatment of neuropathic pain. Voltage-gated sodium channels have been shown to play a critical role in neuropathic pain. With a goal to develop potent peripherally active sodium channel blockers, a series of low molecular weight biaryl substituted imidazoles, oxazoles, and thiazole carboxamides were identified with good in vitro and in vivo potency.</abstract><cop>Amsterdam</cop><pub>Elsevier Ltd</pub><pmid>20709552</pmid><doi>10.1016/j.bmcl.2010.07.064</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0960-894X
ispartof Bioorganic & medicinal chemistry letters, 2010-09, Vol.20 (18), p.5536-5540
issn 0960-894X
1464-3405
language eng
recordid cdi_proquest_miscellaneous_954592005
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Analgesics
Animals
Biaryl imidazoles
Biaryl oxazoles
Biaryl thiazoles
Biological and medical sciences
Dogs
Humans
Imidazoles - chemistry
Imidazoles - metabolism
Imidazoles - pharmacology
Imidazoles - therapeutic use
Medical sciences
Microsomes, Liver - metabolism
Na v1.7 blockers
NAV1.7 Voltage-Gated Sodium Channel
Neuralgia - drug therapy
Neuropathic pain
Neuropathy
Neuropharmacology
Oxazoles - chemistry
Oxazoles - metabolism
Oxazoles - pharmacology
Oxazoles - therapeutic use
Pharmacology. Drug treatments
Rats
Sodium Channel Blockers - chemistry
Sodium Channel Blockers - metabolism
Sodium Channel Blockers - pharmacology
Sodium Channel Blockers - therapeutic use
Sodium Channels - metabolism
Thiazoles - chemistry
Thiazoles - metabolism
Thiazoles - pharmacology
Thiazoles - therapeutic use
Voltage-gated sodium channel
title Substituted biaryl oxazoles, imidazoles, and thiazoles as sodium channel blockers
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T20%3A31%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Substituted%20biaryl%20oxazoles,%20imidazoles,%20and%20thiazoles%20as%20sodium%20channel%20blockers&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry%20letters&rft.au=Tyagarajan,%20Sriram&rft.date=2010-09-15&rft.volume=20&rft.issue=18&rft.spage=5536&rft.epage=5540&rft.pages=5536-5540&rft.issn=0960-894X&rft.eissn=1464-3405&rft_id=info:doi/10.1016/j.bmcl.2010.07.064&rft_dat=%3Cproquest_cross%3E954592005%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=754010973&rft_id=info:pmid/20709552&rft_els_id=S0960894X10010206&rfr_iscdi=true